LEVOXYL Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Levoxyl patents expire, and when can generic versions of Levoxyl launch?
Levoxyl is a drug marketed by King Pharms and is included in one NDA. There are three patents protecting this drug.
This drug has twenty-six patent family members in nine countries.
The generic ingredient in LEVOXYL is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levoxyl
A generic version of LEVOXYL was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for LEVOXYL
| International Patents: | 26 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 111 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,372 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for LEVOXYL |
| Drug Sales Revenues: | Drug sales revenues for LEVOXYL |
| What excipients (inactive ingredients) are in LEVOXYL? | LEVOXYL excipients list |
| DailyMed Link: | LEVOXYL at DailyMed |
Recent Clinical Trials for LEVOXYL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Hospital of Philadelphia | N/A |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | N/A |
Pharmacology for LEVOXYL
| Drug Class | l-Thyroxine |
Anatomical Therapeutic Chemical (ATC) Classes for LEVOXYL
US Patents and Regulatory Information for LEVOXYL
LEVOXYL is protected by three US patents.
Patents protecting LEVOXYL
Levothyroxine compositions and methods
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Methods of administering levothyroxine pharmaceutical compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF USE OF ADMINISTERING LEVOTHYROXINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-011 | May 25, 2001 | AB1,AB3 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
| King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-010 | May 25, 2001 | AB1,AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-011 | May 25, 2001 | AB1,AB3 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LEVOXYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-009 | May 25, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
| King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-008 | May 25, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
| King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-005 | May 25, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LEVOXYL
See the table below for patents covering LEVOXYL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 02067854 | ⤷ Try a Trial | |
| Canada | 2438907 | ⤷ Try a Trial | |
| World Intellectual Property Organization (WIPO) | 03028624 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
NCE-1 Patent Challenge Dates 2023 - 2024
DrugChatter - AI-based answers to questions about drugs
RxJam - Trigger-based marketing for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
